Next-generation sequencing (NGS) has revolutionized the way researchers study DNA and RNA. However, the library preparation step in NGS workflows is still a bottleneck. Library preparation involves multiple manual steps that are time-consuming and require high precision, making it prone to human errors. To overcome this limitation, NGS automation has emerged as a promising solution.
Download Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5271
NGS automation involves the use of robots to perform library preparation, sample processing, sequencing, and bioinformatics analysis, which reduces human errors and enhances accuracy. This technology has the potential to increase efficiency, generate consistent results, and enhance lab productivity. Furthermore, NGS automation can help maintain turnaround times and increase sample throughput, making it particularly useful in high-throughput sequencing applications.
The growing demand for NGS automation is driven by factors such as the increasing incidence of cancer, rising R&D investments, and healthcare expenditure. However, the challenges of regulatory and standardization concerns in diagnostic testing, as well as the requirement for high-skilled personnel to operate automation software, are major barriers to the growth of the market.
In conclusion, NGS automation is a promising technology that can revolutionize the way researchers perform DNA and RNA analysis, by enhancing efficiency, accuracy, and throughput. The development of more advanced NGS automation technologies will help overcome the current limitations of NGS workflows and accelerate scientific discoveries.
The Impact of COVID-19 on the NGS Automation Market
The outbreak of the COVID-19 pandemic and the emergence of new COVID-19 variants has highlighted the importance of next-generation sequencing in identifying and keeping track of the SARS-COV-2 virus mutations. Since 2020, various COVID-19 variants have been identified using next-generation sequencing.
Based on product, in 2022, the workstation/robotic platform segment is estimated to account for the largest share of this market. The large share of this segment is attributed to factors such as the increasing demand for the automation of NGS workflow, the rising adoption of automation workstations/robotic platforms by pharmaceutical and biotechnology companies and in diagnostic laboratories, and the increasing number of funding by governments for drug discovery and research.
Based on application, in 2022, the drug discovery segment is estimated to account for the largest share of this market. The large share of this segment is attributed to the increasing utilization of NGS for identifying novel drug targets and developing therapeutic techniques that target specific genes and proteins, such as targeted therapies, gene therapies, and oligonucleotide therapies, resulting in the increased demand for automation of NGS workflow.
Based on sequencing type, in 2022, the whole genome sequencing segment is estimated to account for the largest share of this market. The large share of this segment is attributed to the advantages of whole-genome sequencing (WGS) in discovery applications, such as identifying causative variants and novel genome assembly, and the ability of this method to detect single nucleotide variants, insertions/deletions, copy number changes, and large structural variants.
In 2022, based on end user, the pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the market. The large share of this segment is attributed to the rising R&D expenditure and the growing demand for new drug discoveries using advanced technologies.
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/ngs-automation-market-5271
The key players operating in the NGS automation market are Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Eppendorf AG (Germany), Hamilton Company (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group Ltd. (Switzerland), PRIMADAG SAS (France), BRAND GMBH + CO KG (Germany), Hudson Robotics (U.S.), SPT Labtech (U.K.), Thermo Fisher Scientific Inc. (U.S.), and F. Hoffmann-La Roche AG (Switzerland).
Key questions answered in the report-
• Which are the high-growth market segments in terms of product, application, sequencing type, end user, and region/country?
• What was the historical market size for the NGS automation market across the globe?
• What are the market forecasts and estimates for the period 2022–2029?
• What are the major drivers, restraints, opportunities, and challenges in the global NGS automation market?
• Who are the major players in the NGS automation market?
• How is the competitive landscape, and who are the market leaders in the global NGS automation market?
• What are the recent developments in the global NGS automation market?
• What are the different strategies adopted by the major players in the global NGS automation market?
• What are the geographical trends and high growth regions/countries?

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5271
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research